T2 Biosystems (TTOO) received an Intention to Grant a European Patent for EP Appl. No. 17205422.3, titled: METHODS FOR AMPLIFYING AND DETECTING PATHOGEN NUCLEIC ACID IN A WHOLE BLOOD SAMPLE - Patent E
Tweet
Share
E-mailGet Alerts TTOO Hot Sheet
Up)Join SI Premium – FREE
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
T2 Biosystems (NASDAQ: TTOO) received an Intention to Grant a European Patent for EP Appl. No. 17205422.3, titled: METHODS FOR AMPLIFYING AND DETECTING PATHOGEN NUCLEIC ACID IN A WHOLE BLOOD SAMPLE - Patent Eagle (LINK)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aaron's (AAN) Appoints Laura N. Bailey, Timothy A. Johnson and Marvonia P. Moore to Board
- Neurocrine Biosciences (NBIX) Announces Johanna Mercier to Board
- PHX Minerals (PHX) Prices Upsized Common Stock Offering at $2/Share
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
